Product_(company,_year_of_approval,_disease)#Revenue_in_million_U.S._dollars
Stelara_(Janssen_2015_CD)#399.5
Xeljanz_(Pfizer_2017_UC)#101.0
Vercimon_(ChemoCentryx_2019_CD)#93.6
Kappaproct_(InDeX_Pharmaceuticals_2014_UC)#47.0
